Ehealth(DE:M5V)
€0.39-0.02 (-5.53%)
DE:M5V
Ehealth stock forecast
€0.39
At close:-0.02 (-5.53%)
Ehealth (M5V) Stock Forecast & Price Target
0 Followers
M5V Analyst Ratings
Hold
0Buy3Hold0Sell
Based on 3 analysts giving stock ratings to Ehealth in the past 3 months
M5V Stock 12 Month Forecast
Average Price Target
€1.05▲(167.53% Upside)Based on 3 Wall Street analysts offering 12 month price targets for Ehealth in the last 3 months. The average price target is EUR 1.05 with a high forecast of EUR 1.80 and a low forecast of EUR 0.68. The average price target represents a 167.53% change from the last price of EUR 0.39.
Past 12 Months12 Month ForecastJan2026Oct2026
High€1.80
Average€1.05
Low€0.68
Highest Price TargetHighest€1.80Average Price Target€1.05Lowest Price TargetLowest€0.68
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Jonathan Yong | UBS | €1.58→€0.68 | hold | 71.98%Upside | Reiterated | 11/06/26 | ||
| George Sutton | Craig-Hallum | €1.35→€0.68 | hold | 71.98%Upside | Reiterated | 11/05/26 | ||
| Ben Hendrix | RBC Capital | €1.80 | hold | 358.62%Upside | Reiterated | 08/24/26 | ||
| George Hill | Deutsche Bank | €2.70→€1.80 | hold | 358.62%Upside | Reiterated | 08/06/26 | ||
| Adam Klauber | William Blair | ― | hold | ― | Reiterated | 08/04/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Jonathan YongUBS | HoldReiterated€1.58→€0.68 | 11/06/26 | 71.98%Upside | ||
| George SuttonCraig-Hallum | HoldReiterated€1.35→€0.68 | 11/05/26 | 71.98%Upside | ||
| Ben HendrixRBC Capital | HoldReiterated€1.80 | 08/24/26 | 358.62%Upside | ||
| George HillDeutsche Bank | HoldReiterated€2.70→€1.80 | 08/06/26 | 358.62%Upside | ||
| Adam KlauberWilliam Blair | HoldReiterated | 08/04/26 | ― |
Stocks with the Highest Top Analyst Consensus in the Financial Sector
M5V Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 5 | 4 | 4 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 6 | 5 | 4 | 4 | 2 |
In the current month, M5V has received 0 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. M5V average Analyst price target in the past 3 months is 1.05.
M5V Financial Forecast
High€2.89
Consensus€2.49
Low€2.21
M5V Earnings Forecast
Next quarter’s earnings estimate for M5V is EUR 2.49 with a range of EUR 2.21 to EUR 2.89. The previous quarter’s EPS was -EUR 1.30. Its overall industry beat the EPS estimate 81.82% of the time in the past 12 months.
High€251M
Consensus€245M
Low€239M
M5V Sales Forecast
Next quarter’s sales forecast for M5V is EUR 244.80M with a range of EUR 239.06M to EUR 251.47M. The previous quarter’s sales results were EUR 19.05M. Its overall industry beat sales estimates 93.33% of the time in the past 12 months.
M5V Stock Forecast FAQ
What is DE:M5V’s average 12-month price target, according to analysts?
Based on analyst ratings, Ehealth’s 12-month average price target is €1.05.
What is DE:M5V’s upside potential, based on the analysts’ average price target?
Ehealth has 167.53% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Ehealth a Buy, Sell or Hold?
Ehealth has a consensus rating of Hold, which is based on 0 buy ratings, 3 hold ratings and 0 sell ratings.
What is Ehealth’s share price target?
The average share price target for Ehealth is €1.05. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €1.80, and the lowest forecast is €0.68. The average share price target represents a 167.53% increase from the current price of €0.393.
What do analysts say about Ehealth?
Ehealth’s analyst rating consensus is a Hold. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of Ehealth?
To buy shares of DE:M5V, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
